Singular, Jo-ann .
HRN: 22-88-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2023
CEFUROXIME 1.5GM (VIAL)
04/18/2023
04/18/2023
IVTT
1.5gm
LD
For Stat CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes